Litcius/Paper detail

Lenvatinib plus Pembrolizumab for Renal Cell Carcinoma

Robert J. Motzer

2021New England Journal of Medicine19 citationsDOI

Topics & Concepts

LenvatinibMedicinePembrolizumabRenal cell carcinomaOncologyCarcinomaInternal medicineMonoclonalNivolumabImmunotherapyCancerAntibodyImmunologyMonoclonal antibodyHepatocellular carcinomaSorafenibRenal cell carcinoma treatmentRenal and related cancersCancer Genomics and Diagnostics